abstract |
The present invention relates to a pharmaceutical composition comprising an effective amount of an angiotensin converting enzyme inhibitor and an effective amount of a matrix metalloproteinase inhibitor. The pharmaceutical composition of the present invention is useful in the treatment of fibrosis, ventricular dilatation, and / or heart failure. SHE |